Quantcast
Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

World's Medical Testing Leader Awarded High Rank in Best Dividend Stocks List

Dividend logo

Gilead Sciences, Inc. (GILD ) is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The company’s primary areas of focus are immunodeficiency virus (HIV), liver diseases, such as chronic hepatitis C virus (HCV) and chronic hepatitis B virus (HBV), oncology and inflammation, and serious cardiovascular and respiratory conditions. The company has two high-profile treatments: Harvoni and Sovaldi. These two drugs accounted for nearly 60% of the company’s revenue in both quarters of 2015.

Additionally, Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands approximately 75% of the U.S. treatment market and more than 50% worldwide.

Gilead Sciences recently started paying a quarterly dividend of $0.43 per share. Its first payout was on 6/29/2015. It’s going Ex-Dividend again on 9/14/2015. Its annual payout comes to $1.72, yielding 1.50% on its current price of $114.

To read the Full Story, Go Premium or Log In

Popular Articles

News

Johnson & Johnson Increases Dividend by 5%

Each day, companies across the globe announce upcoming dividend payouts. In our Dividend Payout...

Premium Shutterstock 128065730
News

The Market Glance for May 22: Monetary Policy, Economic Data Pack One-Two Punch

With corporate earnings season winding down, investors are shifting their attention back to...

News

Union Pacific Leads 150 Stocks Going Ex-Dividend This Week

There are 150 stocks going ex-dividend this week starting Monday, May 22. For income investors...